AVTR241129C19000
- 0.00
- 0.000.00%
Avantor Newsroom
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
Avantor to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Quantum-Si Announced A Distribution Agreement With Avantor To Distribute Quantum-Si's Next-generation Protein Sequencing Portfolio To Researchers Across All Market Segments In Us And Canada
Express News | Quantum-Si Inc - Agreement Expands Access to Proteomics Technology in U.S. and Canada
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing Technology
Express News | Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
Quality Cyclicals Are Expected to Continue Going Up, Here Are the Top-rated by Morgan Stanley
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Express News | Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
Avantor Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
How Is The Market Feeling About Avantor?
Express News | Avantor® Appoints Dame Louise Makin, Dbe, Ph.d., to Its Board of Directors
Press Release: Avantor(R) Appoints Dame Louise Makin, DBE, Ph.D., to Its Board of Directors
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Avantor Is Maintained at Overweight by Wells Fargo
Morgan Stanley Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $27
A Quick Look at Today's Ratings for Avantor(AVTR.US), With a Forecast Between $25 to $28
Avantor Shares Are Trading Higher. Baird Maintained an Outperform Rating on the Stock.
Avantor's Attractive Valuation and Decreasing Leverage Support Buy Rating